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The purpose of this research is to investigate the role of obesity in the pathogenesis of severe COVID‐19 
infection. The relation between obesity and severe COVID-19 has not been completely recorded. PUBMED, 
Cochrane Clinical trials database, Google Scholar and MEDLINE were used to search for literature. 
Comprehensive Meta-analysis software and Excel were used to analyze data. The retrospective cohort study 
examined the correlation between BMI and in patients accepted in intensive care for COVID-19. Nine studies 
were chosen with a total of 340,811 patients were selected. Patients with a severe COVID-19 cases had varying 
pooled odds ratios based on BMI; for BMI of 25-29.9 kg/m2 1.24 (random; 95% CI: 1.03-1.48; p = 0.374; I2 
=0.000), for BMI of 30-34.9 kg/m2 2.01 (random; 95% CI: 1.41-2.88; p = 0.041; I2 = 59.942) and for BMI of 
≥35 kg/m2 2.16 (random; 95% CI: 1.61-2.89; p = 0.172; I2 = 43.242). These studies also showed a linear 
increase in percentage of severe COVID-19 cases based on increasing BMI. The present study indicates a high 
frequency of obesity among patients accepted in intensive care for COVID-19. Disease severity escalates with 
Body mass index (BMI). Obesity is a risk factor for COVID-19 severity. Awareness of this severity is needed to 
be spread widely so as to curtail overweight or obesity. 
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The coronavirus disease 2019 (COVID‐19) is the cause of a speedily progressing pandemic. It originates from a 
viral respiratory disease known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid 
spread of this virus led to the public announcement of a pandemic by the World Health Organization on the 11th 
March 2020[1]. Researchers believe that patients at risk for severe acute respiratory syndrome COVID-19 have 
been marked as having preexisting diseases, such as cardiovascular disease, high blood pressure, obesity, 
chronic lung disease, diabetes or heart disease, chronic respiratory disease, or cancer while others singled out an 
increase in BMI with few other comorbidities as the major risk factors for COVID-19[2].  Obesity is considered 
as an unusual or excessive fat collection that presents a risk to health and predisposes the body with risk of other 
diseases and health problems, such as heart disease, diabetes and COVID-19[3,4]. A body mass index (BMI) is 
a criterion used to identify one as obese. If BMI is less than 18.5 kg/m2, it is considered as underweight.  But if 
it within 18.5 to 24 kg/m2, is considered normal and if it is from 25 to 29 kg/m2, is seen as overweight[5]. 
Obesity has different grades, for example: if BMI is measured from 30 to 34 kg/m2, is considered as obese class 
I. While from 35 to 39 kg/m2, is seen as obese class II and finally if it is greater than 40 kg/m2, is considered as 
obese class III or extreme obesity[6]. Our research will be concentrating on BMI from 25 kg/m2 upwards.  The 
purpose of this research, firstly, is to establish the fact that obesity plays a severe role in the pathogenesis of 
COVID‐19 infection. This is so, considering the fact, obese persons secrete excess free fatty acids which will 
induce lipo-toxicity that cause damage to many organs including the respiratory system and thus, contribute to 
worsening of COVID-19. Obesity induces cytokines release such as tumor necrosis factor alpha, monocyte 
chemoattractant protein-1, and interleukin-6 that causes hypertension via renin-angiotensin-aldosterone system 
activation. These cytokines will cause damage to vascular endothelium and induce symptoms such as fatigue or 
confusion, chest pain, difficulty breathing or irregular heartbeat often seen in COVID-19 patients[7]. Secondly, 
to let the general population be aware of danger of obesity and also to trigger the minds of many scholars and 
researches to pay more attention on obesity without other comorbidities as a risk factor in the severity of 
COVID-19. This urgency is needed, considering the fact that over two-thirds of Westernized society are 
overweight or obese[8]. These findings can have a significant impact on the evaluation of patients and 
implications for policy. Therefore, obese patients are amongst groups at high risk and should be advised to take 
preventive precautions such as hand hygiene and social distancing to prevent being contaminated by coronavirus 
disease. It is also vital to engage in regular exercise, and avoid high calorie diets which contributes to weight 
gain[3].  
2. Method 
The present study seeks to demonstrate a relationship between individuals with obesity and severity of COVID-
19. “Severe COVID-19 case” was defined as patients that tested positive for COVID-19 and required ICU 
and/or assisted ventilation. With this in mind, a search through databases were made. PUBMED, Cochrane 
Clinical trials database, Google Scholar and MEDLINE were the main databases used to search for literature. 
Key subject searches included “obesity and COVID19”, “obesity and severe COVID19”, “obesity ventilator and 
COVID19” and “obesity ICU and COVID19”. Initially, there was a manual literature search screening title 
headings and abstracts. This initial search was based on the inclusion and exclusion criteria shown in Figure 1.  
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Furthermore, the references of included articles were searched to identify other potentially relevant studies. The 
search was focused on studies published in English during 2020. After the selection of certain studies, a more 
thorough inclusion/exclusion process was conducted by reading each study in its entirety. The studies that met 
all criteria were included in the meta-analysis (Figure 2). 
 
Figure 1: Flow chart showing selection process of literature. 
For data analysis of odds ratios Comprehensive Meta-analysis software was used. Graphical representation of 
percentage of severe COVID-19 cases based on BMI compared to non-severe cases, was completed through 
Excel.   
3. Results 
Of the 57 studies identified, 9 studies were included that met all inclusion criteria (Figure 2). The following data 
was extracted: location, study dates, study design, sample size, odds ratios, hazard ratio, confidence intervals, p-
values, and prevalence of severe cases by BMI (%). There was a total of 340, 811 patients from these 9 selected 
studies. Description of these studies are included in Table 1. All 9 studies overlap in time based on study dates.  
 
 
All Studies of Obesity 
and COVID-19
Studies included in 
Meta-analysis
Include studies from 
all countries
Include studies of at least 
100 patients
Exclude studies with 
participants under the age 
of 18
Exclude case studies, 
opinion articles, and 
editorials 
Exclude studies centered 
on additional 
cormobitidies 
Exclude studies that focus 
on specific population (eg., 
gender, race)
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Table 1: Characteristics of studies that met criteria 
Study Study Dates Country Study Design  Population 
Hammer and 
colleagues 
Mar 16 – Apr 26 UK Retrospective Cohort 334, 329 
Simonnet and 
colleagues 
Feb 27 – Apr 5 France Retrospective Cohort 124 
Caussy and 
colleagues 
Mar 27* France Retrospective Cohort 1210 
Lighter and 
colleagues 
Mar 3 – Apr 4 USA  Retrospective Cohort 3615 
Pettit     and 
colleagues 
Mar 1 – Apr 18 USA Retrospective Cohort 238 
Cai       and 
colleagues 
Jan 11– Mar 26 China Prospective Cohort 383 
Kalligeros and 
colleagues 
Feb 17 – Apr 5 USA Retrospective Cohort 103 
Nakeshbandi and 
colleagues 
Mar 10 – Apr 3 USA Retrospective Cohort 504 
Frank   and 
colleagues 
Mar 13 – Apr 3 USA Retrospective Cohort 305 
*Start date was not included 
 
Figure 2: Flow chart showing number of studies excluded and included during selection process of literature 
Of the 9 selected studies, 6 included data of percent severity of COVID-19 based on four BMI brackets: <25 
kg/m2, 25-29.9 kg/m2, 30-34.9 kg/m2, and ≥35 kg/m2. These 6 studies were used to show the general trend of 
percentage of severe cases as BMI increased. The results show a linear increase in percentage of severe COVID-
19 cases based on increasing BMI (Table 2, Figure 3). All studies show an increase in percentage of severe 
Studies from published 
English literture
n = 57
Studies included in 
Meta-analysis
n = 9




n = 5 
Excluded based on full 
length analysis
n = 11
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cases as BMI increases with the exception of Pettit and colleagues and Kalligeros and colleagues studies[6,7]. In 
both studies the only results that do not follow this trend is seen between BMI of 25-29.9 kg/m2 showing a 
higher percentage of cases compared to 30-34.9 kg/m2.  
Table 2: Percent of severe COVID-19 cases based on BMI compared to non-severe cases 











30 38 52 51 0.006 
Pettit and 
colleagues 
23.30 34 25.40 53.50 0.77 
Cai and 
colleagues 
19.20 29.30 39 39 0.001 
Simmonet and 
colleagues 
47.10 60.40 75 85.70 0.01 
Kalligeros and 
colleagues 
11.30 31.80 25 31.80 - 
Nakeshbandi and 
colleagues 
12 24 38 38 0.002 
 
Figure 3:  Percentage of severe COVID-19 cases based on BMI compared to non-severe cases 
Odds ratios were included in 5 of the 9 studies, based on the following BMI brackets: 25-29.9 kg/m2, 30-
34.9 kg/m2, and ≥35 kg/m2. These findings are presented in the forest plots in Figure 4. Three studies that 
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provided odds ratios of patients with a BMI of 25-29.9 kg/m2 showed an overall pooled odds ratio of 1.24 
(random; 95% CI: 1.03-1.48) and a low heterogeneity (p = 0.374; I2 =0.000). Five studies with odds ratios of 
patients with a BMI of 30-34.9 kg/m2 had overall pooled odds ratio of 2.01 (random; 95% CI: 1.41-2.88) and a 
moderate heterogeneity (p = 0.041; I2 = 59.942). Three studies that provided odds ratios of patients with a BMI 
of ≥ 35 kg/m2 showed an overall pooled odds ratio of 2.16 (random; 95% CI: 1.61-2.89) and a moderate 
heterogeneity (p = 0.172; I2 = 43.242). These results suggest a significant association between COVID-19 
severity and obesity in all three groups of BMIs.  
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p-value  Sample Size  
 Frank and 
colleagues 
2.1 - 1.2-3.9 0.02 305 
Simonnet and 
colleagues 
- 7.36 1.63-33.14 0.01 124 
Caussy and 
colleagues 
- 1.69 1.10-2.56 0.017 1210 
 Lighter and 
colleagues 
- 2 1.6-2.6 0.001 3615 
 Pettit and 
colleagues 
- 1.7 1.1-2.8 0.016 238 
Unfortunately, not all studies included in this paper provided p-values. Of the studies that did include p-values, 
5 had significant results (Table 3). These studies found a significant association between patient BMI and 
severity of COVID-19.  
4. Discussion 
4.1 Primary outcome 
In this meta-analysis consisting of 9 studies with a total of 340,811 patients, we determined that increasing BMI 
levels is associated with COVID-19 severity in which patients are either admitted to an ICU or placed on a 
ventilator. The severity pooled odds ratios after adjusting for heterogeneity for each BMI category includes BMI 
of 25-29.9 kg/m2 1.24 (random; 95% CI: 1.03-1.48; p = 0.374; I2 =0.000), BMI of 30-34.9 kg/m2 2.01 (random; 
95% CI: 1.41-2.88; p = 0.041; I2 = 59.942), and BMI of ≥ 35 kg/m2 2.16 (random; 95% CI: 1.61-2.89; p = 0.172; 
I2 = 43.242); all of which are significantly high. The primary focus of this meta-analysis was to study the 
association of obesity with the severity of COVID-19 disease. We determined that as a patient’s BMI increases, 
they are more likely to develop COVID-19 severity. Patients with BMI ≥25 kg/m2 and COVID-19 are more 
likely to require ICU admission or a mechanical ventilator. Our current investigations corroborate with the 
findings of Sales-Peres and de Azevedo-Silva and colleagues [11]. Another study by Luzi and Radaelli [16], 
justified the relationship between BMI and COVID-19 severity. It has been suggested that three factors make 
obese individuals infected with COVID-19 more contagious than normal weight individuals: (a) obese 
individuals with influenza shed the virus for a longer period of time, possibly raising the ability to transmit the 
virus to others [17]; (b) due to the decreased and delayed capacity of obese individuals to produce interferons, 
the obese microenvironment favors the emergence of novel strains. The delay in the development of interferon 
to oppose viral replication in turn enables further replication of viral RNA, raising the likelihood of new, more 
virulent viral strains emerging [18]; and (c) the body mass index (BMI) correlates positively with severity in 
COVID-19 patients [19]. Table 2 and Figure 3 presents the intercorrelation between severity of COVID-19 
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cases and BMI. Recently, a retrospective study from Lille, France by Simmonet and colleagues demonstrated a 
spike in prevalence of severe COVID-19 cases with 47.10% (<25 kg/m2), 60.40% (25-29.9 kg/m2), 75% (30-
34.9 kg/m2), and 85.70% (≥35 kg/m2)[12]. In all the studies on Table 2, a BMI ≥ 35 kg/m2 has the greatest risk 
factor in disease severity. There is a 1.7-fold to 3.1-fold increase from normal-weight to BMI ≥ 35 kg/m2 
patients requiring ICU admission or invasive mechanical ventilation. The most drastic fold increases are seen in 
the studies from Kalligeros and colleagues and Nakeshbandi and colleagues being 2.8 and 3.1 
respectively[7,10]. Similarly, Simmonet and colleagues study also has the greatest odds ratio and largest 95% 
confidence interval (see Table 3) with the odds ratio for severity in patients with BMI >35 kg/m2 versus patients 
with BMI < 25 kg/m2, being 7.36 (1.63-33.14; P = 0.02)[12]. A New York study by Lighter and colleagues also 
showed results that, patients with BMI between 30-34.9 kg/m2 were two times more likely to be severe cases 
when compared to patients with BMI < 30 kg/m2 (Figure 4C)[13]. Frank and colleagues retrospective cohort 
study in Massachusetts, USA assessed whether obesity is a strong independent risk factor of severity[14]. They 
compared COVID-19 patients of different BMIs and found obesity in the absence of other comorbidities, there 
is an increased risk of invasive mechanical ventilation, ICU admission or death. Obese patients were at higher 
risk of immune dysfunction and pneumonia. They found that excess body weight and poor pulmonary reserve 
seen in obesity causes impaired respiratory mechanics and restrictive lung physiology that may contribute to 
worsening of COVID-19. 
4.2 Pathogenesis 
The pathogenesis of increased COVID-19 severity in patients with obesity is still unknown. Obesity causes 
impairment of the adaptive immune response against influenza and other viruses. The influenza A H1N1 
epidemic in 2009 had also resulted in increased severity and death in patients with obesity[12]. Excess free fatty 
acids seen in obesity induces lipo-toxicity which causes damage to many organs. Damage to the liver and 
pancreas leads to impairment of insulin receptors causing insulin resistance, hypertriglyceridemia, and 
progression to metabolic syndrome[7]. Obesity also induces a pro-inflammatory state by increasing the 
expression of cytokines (tumor necrosis factor alpha, monocyte chemoattractant protein-1, interleukin-6), C-
reactive protein, and amyloid antigen. These cytokines cause hypertension by renin-angiotensin-aldosterone 
system activation, damage to vascular endothelium, atherosclerosis, and thrombosis[7]. There is also a decrease 
in anti-inflammatory adipokine (adiponectin) concentrations which causes dysregulation in immune response[9]. 
Pulmonary dysfunction is also seen in obesity such as a hypoxemia, ventilation/perfusion defects, and a decrease 
in functional residual capacity and expiratory reserve volume[10]. Adipose tissue expresses a high level of 
angiotensin-converting enzyme 2 (ACE2) which is a receptor that COVID-19 has a high affinity for[10]. 
4.3 Strengths  
This is one of the few large meta-analysis exploring the specific influence obesity has on the severity of 
COVID-19. A major strength of this meta-analysis is that we included large racially and ethnically diverse 
studies from around the world. Multiple databases were searched and studies from the US, UK, France, and 
China were gathered. The study setting and author list of each article were carefully reviewed. We limited our 
search to English studies only and ensured to avoid any duplications. Each study has more than 100 patients 
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which strengthens the data on the obesity–COVID-19 association. While processing the results, we have 
adjusted for heterogeneity and other potential biases with the appropriate statistical tools.  
4.4 Implications 
The results of our meta-analysis have major clinical implications and contributions during the current COVID-
19 pandemic. Our findings further establish that patients with obesity are at greater risk for severe disease in 
COVID-19. Given the high prevalence of obesity in the general population and that over two-thirds of 
Westernized society are overweight or obese, these findings can have a significant impact on the evaluation of 
patients and implications for policy[8].  Prevention of COVID-19 in obese patients is imperative as they are at 
risk for increased disease severity. Medical professionals should recognize that obesity is a risk factor in 
COVID-19 severity and adjust their prioritization for higher level care or drug resources accordingly. Obese 
patients should be advised to take prevention precautions such as hand hygiene and social distancing to protect 
themselves from COVID-19 contamination[12,15]. Out-patient clinics and hospitals should be hypervigilant of 
obesity for COVID-19 and lower the threshold for testing, extra monitoring and ICU admission for obese 
patients. Future COVID-19 reporting studies should include obesity as a comorbidity and further explore the 
mechanisms that cause increase disease severity. Streamlining prevention and treatment strategies is warranted 
for these patients. 
4.5 Limitations 
Our meta-analysis has a few limitations. Although we have established that obesity is associated with COVID-
19 severity; we were unable to assess the effect that BMI has on mortality the rate of COVID-19 patients 
because of insufficient data. Further more, systemic literature searching should recognize studies that showed a 
relationship of increasing BMI with more likelihood of severe cases of COVID-19, but would also include 
studies that investigated the opposite effect (increasing BMI not affecting the likelihood of severe COVID-19 
cases). Unfortunately, there is lack of research in this area. Once this gap in research is filled, a stronger, more 
balanced meta-analysis may be conducted. Additionally, some of the studies’ 95% confidence intervals were 
relatively wide (Simonnet and colleagues Kalligeros and colleagues Cai and colleagues), which may be due to 
the small sample size. Also, in some of the studies the predominant population is minorities[7,9,20]. This may 
not be a true representation of the general population as obesity rates are higher in minorities such as African 
Americans. In order to determine if obese population are more susceptible to COVID-19 infection compared to 
the general population, further studying of true prevalence would be necessary.  
5. Conclusion 
In this study, we carry out a meta-analysis and systematic appraisal of nine articles with the aim of evaluating 
the validity of obesity as one of the main causes of increased severity of COVID-19. We found that higher BMI 
is a risk factor for progression to severe COVID-19. 
 




The most obvious finding to emerge from this study established obesity as a factor in COVID-19 disease 
severity. Therefore, we recommend the following steps to mitigate an underlining condition such as Obesity that 
can increase a person’s chances of having a severe illness from COVID-19 infection: 
1. Ensuring easy access for obesity screening and awareness among early care and education settings 
2. Feeding on a healthy diet (Good nutrition) can help support optimal immune functions. 
3. Being active with regular physical activity for calorie reduction in weight loss 
However, further study could assess the relationship between mortality rate and obesity among COVID-19 
patient, another possible area of future research would be to investigate the relationship between severity of 
COVID-19 and obesity for critically ill patients requiring intensive care unit (ICU) care while a large number of 
randomized controlled trials could provide more definitive evidence. 
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